Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F16%3AN0000044" target="_blank" >RIV/00023728:_____/16:N0000044 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/16:10323820 RIV/00216208:11130/16:10323820 RIV/00064203:_____/16:10323820
Result on the web
<a href="http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=6&SID=Z2caO8kTQm461hEFj72&page=1&doc=1" target="_blank" >http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=6&SID=Z2caO8kTQm461hEFj72&page=1&doc=1</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients
Original language description
The aim of this study was to evaluate serum levels of visfatin in anti-Jo-1-positive myositis patients, its expression in muscle tissue and to investigate potential relationships between visfatin, B-cell activating factor of the TNF family (BAFF), disease activity and anti-Jo-1 autoantibody levels.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)